Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) acquired Medicis Pharmaceutical Corporation ("Medicis") following the approval of the transaction
by stockholders of Medicis at the special meeting held on December 7, 2012. Valeant acquired all of the common stock of Medicis outstanding at the time of the completion
of the acquisition for $44.00 per share in cash.
For more information, please click here